Biological medication for rheuma

PheWeb

RX_RHEUMA_BIOLOGICAL

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L04AA24|L04AC03|L04AB04|L04AB01|L04AB06|L04AB02|L04AB05|L04AA26|L01XC02|L04AC10|L04AC07|L04AC05

3383

Check pre-conditions, main-only, mode, ICD version None

3250

Check minimum number of events

Min. number of events 3

3250

Include endpoints None

3250

RX_RHEUMA_BIOLOGICAL

Extra metadata

First used in FinnGen datafreeze DF5

Similar endpoints

↥

List of similar endpoints to Biological medication for rheuma based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	3139	1930	1209
Unadjusted prevalence (%)	1.02	1.11	0.90
Mean age at first event (years)	47.08	46.90	47.35

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	2.24 [1.36, 3.70]	1.5e-3	34
15 years	0.01	1.19 [0.66, 2.14]	5.7e-1	18
5 years	0.00	1.55 [0.77, 3.13]	2.2e-1	10
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_RHEUMA_BIOLOGICAL – Biological medication for rheuma
GWS hits: 10

Survival analyses between endpoints

↥

Plot

before Biological medication for rheuma
after Biological medication for rheuma

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Biological medication for rheuma

↥